|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 125.7 USD | +3.47% |
|
+8.49% | +26.62% |
| 07-15 | Moderna Insider Sold Shares Worth $1,756,177, According to a Recent SEC Filing | MT |
| 07-12 | China approves CSPC Pharma's RSV vaccine for clinical trials | RE |
(Reuters) - Moderna Inc said on Monday it would produce at least 600 million doses of its COVID-19 vaccine in 2021, up by 100 million doses from its previous forecast, as the United States continues to roll-out the vaccine.
The company was working to invest and hire in order to deliver up to 1 billion doses this year, the higher end of its production forecast, it said.
Moderna said it has so far supplied about 18 million doses to U.S. government as part of a deal for 200 million doses. It has also signed a deal with the Canadian government for 40 million doses.
(This story refiles to add dropped word in paragraph two)
(Reporting by Manas Mishra in Bengaluru; Editing by Arun Koyyur)
| 1st Jan change | Capi. | |
|---|---|---|
| +26.62% | 46.56B | |
| +45.38% | 41.67B | |
| +0.50% | 41.16B | |
| +32.06% | 32.4B | |
| +20.92% | 28.18B | |
| -6.35% | 28.1B | |
| +49.52% | 14.52B | |
| +48.30% | 13.74B | |
| +3.56% | 12.17B | |
| -3.79% | 11.14B |
MODERNA, INC. 
